S&P 500

5.267,84

-0,74%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Arch Therapeutics Inc (QB) (ARTHD)
Arch Therapeutics Inc (QB) (ARTHD) Notícias

ARTHD

Arch Therapeutics (QB) (ARTHD)

Arch Therapeutics Inc (QB)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:ARTHD

1

Data	Hora	Fonte	Título	Código	Companhia
21/05/2024	17:30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ARTHD	Arch Therapeutics Inc (QB)
09/05/2024	17:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:ARTHD	Arch Therapeutics Inc (QB)
01/03/2024	18:30	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	USOTC:ARTHD	Arch Therapeutics Inc (QB)
15/02/2024	18:30	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ARTHD	Arch Therapeutics Inc (QB)
22/01/2024	14:39	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ARTHD	Arch Therapeutics Inc (QB)
29/12/2023	18:30	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	USOTC:ARTHD	Arch Therapeutics Inc (QB)
05/10/2023	18:27	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	USOTC:ARTHD	Arch Therapeutics Inc (QB)
08/09/2023	18:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ARTHD	Arch Therapeutics Inc (QB)
01/09/2023	17:30	Edgar (US Regulatory)	Form DEF 14C - Other definitive information statements	USOTC:ARTHD	Arch Therapeutics Inc (QB)
22/08/2023	17:52	Edgar (US Regulatory)	Form PRE 14C - Other preliminary information statements	USOTC:ARTHD	Arch Therapeutics Inc (QB)
09/08/2023	12:16	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:ARTHD	Arch Therapeutics Inc (QB)
22/06/2023	17:31	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ARTHD	Arch Therapeutics Inc (QB)
23/05/2023	07:02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ARTHD	Arch Therapeutics Inc (QB)
16/05/2023	07:01	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ARTHD	Arch Therapeutics Inc (QB)
25/01/2023	17:19	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ARTHD	Arch Therapeutics Inc (QB)
23/01/2023	19:18	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:ARTHD	Arch Therapeutics Inc (QB)